1. Home
  2. BVS vs VNDA Comparison

BVS vs VNDA Comparison

Compare BVS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.97

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.27

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
VNDA
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.1M
474.0M
IPO Year
2016
2005

Fundamental Metrics

Financial Performance
Metric
BVS
VNDA
Price
$9.97
$7.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$14.00
$14.90
AVG Volume (30 Days)
416.1K
1.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
N/A
EPS
0.33
N/A
Revenue
$568,087,000.00
$216,105,000.00
Revenue This Year
$7.52
$21.35
Revenue Next Year
$7.06
$37.40
P/E Ratio
$29.97
N/A
Revenue Growth
N/A
8.72
52 Week Low
$5.81
$3.81
52 Week High
$9.98
$9.91

Technical Indicators

Market Signals
Indicator
BVS
VNDA
Relative Strength Index (RSI) 69.02 47.26
Support Level $8.43 $7.12
Resistance Level N/A $8.29
Average True Range (ATR) 0.35 0.33
MACD 0.05 0.02
Stochastic Oscillator 100.00 58.20

Price Performance

Historical Comparison
BVS
VNDA

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: